Characterization of serotonin neurotransmission in knockout mice: Implications for major depression

Reviews in the Neurosciences

Volumn 23, Issue 4, 2012, Pages 429-443

  Domínguez López, Sergio ^a   Howell, Rebecca ^a   Gobbi, Gabriella ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Behavioral phenotype; Depression; Knockout mouse; Neurotransmission; Serotonin; Translational studies

Indexed keywords

FATTY ACID AMIDASE; NEUROKININ 1 RECEPTOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNK2; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; AMIDASE; FATTY-ACID AMIDE HYDROLASE; POTASSIUM CHANNEL PROTEIN TREK 1; POTASSIUM CHANNEL PROTEIN TREK-1; SEROTONIN RECEPTOR; TANDEM PORE DOMAIN POTASSIUM CHANNEL;

COPING BEHAVIOR; ELECTROPHYSIOLOGY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; KNOCKOUT MOUSE; MAJOR DEPRESSION; MOOD DISORDER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC TRANSMISSION; ANIMAL; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

AMIDOHYDROLASES; ANIMALS; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICE; MICE, KNOCKOUT; NEURONS; PHENOTYPE; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RECEPTORS, NEUROKININ-1; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION;

EID: 84868666826     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro-2012-0044     Document Type: Review

References (151)

1. Adell, A., Castro, E., Celada, P., Bortolozzi, A., Pazos, A., and Artigas, F. (2005). Strategies for producing faster acting anti depressants. Drug Discov. Today 10, 578-585. (Pubitemid 40552825)
2. Albert, P.R., Zhou, Q.Y., Van Tol, H.H., Bunzow, J.R., and Civelli, O. (1990). Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine 1a receptor gene. J. Biol. Chem. 265, 5825-5832.
3. Alloui, A., Zimmermann, K., Mamet, J., Duprat, F., Noel, J., Chemin, J., Guy, N., Blondeau, N., Voilley, N., Rubat-Coudert, C., et al. (2006). TREK-1, a K+ channel involved in polymodal pain perception. EMBO J. 25, 2368-2376. (Pubitemid 44012220)
4. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. (Arlington, VA, USA: American Psychiatric Association).
5. Arango, V., Underwood, M., Boldrini, M., Tamir, H., Kassir, S., Hsiung, S., Chen, J., and Mann, J. (2001). Serotonin 1a receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25, 892-903. (Pubitemid 34031894)
6. Artigas, F. (1993). 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol. Sci. 14, 262. (Pubitemid 23204242)
7. Ase, A.R., Reader, T.A., Hen, R., Riad, M., and Descarries, L. (2000). Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT 1A or 5-HT1B receptor knockout mice. J. Neurochem. 75, 2415-2426.
8. Bambico, F.R. and Gobbi, G. (2008). The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Expert Opin. Ther. Targets 12, 1347-1366.
9. Bambico, F.R., Katz, N., Debonnel, G., and Gobbi, G. (2007). Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci. 27, 11700-11711. (Pubitemid 350006914)
10. Bambico, F., Cassano, T., Dominguez-Lopez, S., Katz, N., Walker, C., Piomelli, D., and Gobbi, G. (2010). Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus. Neuropsychopharmacology 35, 2083-2100.
11. Bengel, D., Murphy, D.L., Andrews, A.M., Wichems, C.H., Feltner, D., Heils, A., Mössner, R., Westphal, H., and Lesch, K.-P. (1998). Altered brain serotonin homeostasis and locomotor insensitivity to 3,4- methylenedioxymethamphetamine ( " ecstasy " ) in serotonin transporter-deficient mice. Mol. Pharmacol. 53, 649-655. (Pubitemid 28196486)
12. Bhagwagar, Z., Rabiner, E., Sargent, P., Grasby, P., and Cowen, P. (2004). Persistent reduction in brain serotonin 1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol. Psychiatry 9, 386-392. (Pubitemid 38534699)
13. Blier, P. and de Montigny, C. (1994). Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220-226. (Pubitemid 24210726)
14. Bockaert, J., Claeysen, S., Compan, V., and Dumuis, A. (2008). 5-HT(4) receptors: history, molecular pharmacology and brain functions. Neuropharmacology 55, 922-931.
15. Bockaert, J., Claeysen, S., Compan, V., and Dumuis, A. (2011). 5-HT(4) receptors, a place in the sun: act two. Curr. Opin. Pharmacol. 11, 87-93.
16. Bodnoff, S.R., Suranyi-Cadotte, B., Quirion, R., and Meaney, M.J. (1989). A comparision of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacol. (Berl.) 97, 277-279. (Pubitemid 19040176)
17. Boldrini, M., Underwood, M.D., Mann, J.J., and Arango, V. (2008). Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J. Psychiatr. Res. 42, 433-442. (Pubitemid 351240919)
18. Bonaventure, P., Hall, H., Gommeren, W., Cras, P., Langlois, X., Jurzak, M., and Leysen, J.E. (2000). Mapping of serotonin 5-HT(4) receptor mRNA and ligand binding sites in the post-mortem human brain. Synapse 36, 35-46. (Pubitemid 30134123)
19. Bortolozzi, A., Amargós-Bosch, M., Toth, M., Artigas, F., and Adell, A. (2004). In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT 1A receptor knockout mice. J. Neurochem. 88, 1373-1379. (Pubitemid 38366912)
20. Burnet, P.W.J. and Harrison, P.J. (2000). Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia. Biol. Psychiatry 47, 80-83. (Pubitemid 30016083)
21. Carola, V., Frazzetto, G., Pascucci, T., Audero, E., Puglisi-Allegra, S., Cabib, S., Lesch, K.-P., and Gross, C. (2008). Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression. Biol. Psychiatry 63, 840-846. (Pubitemid 351458447)
22. Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389. (Pubitemid 36877077)
23. Caspi, A., Hariri, A.R., Holmes, A., Uher, R., and Moffitt, T.E. (2010). Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am. J. Psychiatry 167, 509-527.
24. Cassano, T., Gaetani, S., Macheda, T., Laconca, L., Romano, A., Morgese, M., Cimmino, C., Chiarotti, F., Bambico, F., Gobbi, G., et al. (2011). Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolasedeficient mice. Psychopharmacol. (Berl.) 214, 465-476.
25. Castagne, V., Moser, P., Roux, S., and Porsolt, R.D. (2011). Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr. Protoc. Neurosci. Chapter 8, Unit 8. 10A.
26. Christensen, R., Kristensen, P.K., Bartels, E.M., Bliddal, H., and Astrup, A. (2007). Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370, 1706-1713. (Pubitemid 350100788)
27. Compan, V., Zhou, M., Grailhe, R., Gazzara, R.A., Martin, R., Gingrich, J., Dumuis, A., Brunner, D., Bockaert, J., and Hen, R. (2004). Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. J. Neurosci. 24, 412-419. (Pubitemid 38112372)
28. Conductier, G., Dusticier, N., Lucas, G., Cote, F., Debonnel, G., Daszuta, A., Dumuis, A., Nieoullon, A., Hen, R., Bockaert, J., et al. (2006). Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knock-out mouse. Eur. J. Neurosci. 24, 1053-1062. (Pubitemid 44268136)
29. Cour, C.M.l., Boni, C., Hanoun, N.M., Lesch, K.-P., Hamon, M., and Lanfumey, L. (2001). Functional consequences of 5-HT transporter gene disruption on 5-HT 1A receptor-mediated regulation of dorsal raphe and hippocampal cell activity. J. Neurosci. 21, 2178-2185. (Pubitemid 32221400)
30. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A., and Gilula, N.B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87. (Pubitemid 26374593)
31. Cravatt, B.F., Demarest, K., Patricelli, M.P., Bracey, M.H., Giang, D.K., Martin, B.R., and Lichtman, A.H. (2001). Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Nat. Acad. Sci. USA 98, 9371-9376. (Pubitemid 32743923)
32. Cryan, J. and Holmes, A. (2005). The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 4, 775-790. (Pubitemid 43090498)
33. Dableh, L., Yashpal, K., Rochford, J., and Henry, J. (2005). Anti depressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat. Eur. J. Pharmacol. 507, 99-105. (Pubitemid 40126845)
34. Dahlstroem, A. and Fuxe, K. (1964). Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 62(Suppl. 232), 1-55.
35. Datar, P., Srivastava, S., Coutinho, E., and Govil, G. (2004). Substance P: structure, function, and therapeutics. Curr. Top. Med. Chem. 4, 75-103. (Pubitemid 38849358)
36. Dean, B., Tomaskovic-Crook, E., Opeskin, K., Keks, N., and Copolov, D. (1999). No change in the density of the serotonin-1A receptor, the serotonin-4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia. Neurochem. Int. 34, 109-115. (Pubitemid 29148374)
37. De Felipe, C., Herrero, J., O'Brien, J., Palmer, J., Doyle, C., Smith, A., Laird, J., Belmonte, C., Cervero, F., and Hunt, S. (1998). Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392, 394-397. (Pubitemid 28168736)
38. Deng, P.-Y., Poudel, S.K.S., Rojanathammanee, L., Porter, J.E., and Lei, S. (2007). Serotonin inhibits neuronal excitability by activating two-pore domain K+ channels in the entorhinal cortex. Mol. Pharmacol. 72, 208-218. (Pubitemid 46998540)
39. Descarries, L., Watkins, K.C., Garcia, S., and Beaudet, A. (1982). The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J. Comp. Neurol. 207, 239-254. (Pubitemid 12081283)
40. Di Fabio, R., Alvaro, G., Griffante, C., Pizzi, D.A., Donati, D., Mattioli, M., Cimarosti, Z., Guercio, G., Marchioro, C., Provera, S., et al. (2011). Discovery and biological characterization of (2r,4s)-1'-acetyl-n-{(1r)- 1-[3,5-bis(trifluoromethyl) phenyl] ethyl}-2-(4-fluoro-2-methylphenyl)-n-methyl- 4,4'-bipiperidine- 1-carboxamide as a new potent and selective neurokinin 1 (NK1) receptor antagonist clinical candidate. J. Med. Chem. 54, 1071-1079.
41. Dillon, D.G., Bogdan, R., Fagerness, J., Holmes, A.J., Perlis, R.H., and Pizzagalli, D.A. (2010). Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans. Hum. Brain Mapp. 31, 210-221.
42. Domínguez-López, S., Mahar, I., Bambico, F.R., Labonte, B., Ochoa-Sanchez, R., Leyton, M., and Gobbi, G. (2012) Short term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle. J. Psychopharmacol. 26, 830-844.
43. Drevets, W., Thase, M., Moses-Kolko, E., Price, J., Frank, E., Kupfer, D., and Mathis, C. (2007). Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl. Med. Biol. 34, 865-877. (Pubitemid 47505401)
44. Egertová, M., Giang, D.K., Cravatt, B.F., and Elphick, M.R. (1998). A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc. Roy. Soc. Biol. 265, 2081-2085. (Pubitemid 28502544)
45. Fabre, V., Beaufour, C., Evrard, A., Rioux, A., Hanoun, N., Lesch, K.P., Murphy, D.L., Lanfumey, L., Hamon, M., and Martres, M.P. (2000). Altered expression and functions of serotonin 5-HT 1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur. J. Neurosci. 12, 2299-2310. (Pubitemid 30497028)
46. Fargin, A., Raymond, J., Lohse, M., Kobilka, B., Caron, M., and Lefkowitz, R. (1988). The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT 1A receptor. Nature 335, 358-360.
47. Fink, M., Duprat, F., Lesage, F., Reyes, R., Romey, G., Heurteaux, C., and Lazdunski, M. (1996). Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel. EMBO J. 15, 6854-6862.
48. Fong, T.M., Anderson, S.A., Yu, H., Huang, R.R., and Strader, C.D. (1992). Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol. Pharmacol. 41, 24-30.
49. Freund, T.F., Katona, I., and PiomelliI, D. (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 1017-1066. (Pubitemid 36828930)
50. Frisch, P., Bilkei-Gorzo, A., Racz, I., and Zimmer, A. (2010). Modulation of the CRH system by substance P/NKA in an animal model of depression. Behav. Brain Res. 213, 103-108.
51. Froger, N., Gardier, A.M., Moratalla, R., Alberti, I., Lena, I., Boni, C., De Felipe, C., Rupniak, N.M.J., Hunt, S.P., Jacquot, C., et al. (2001). 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. J. Neurosci. 21, 8188-8197. (Pubitemid 32952774)
52. George, D.T., Gilman, J., Hersh, J., Thorsell, A., Herion, D., Geyer, C., Peng, X., Kielbasa, W., Rawlings, R., Brandt, J.E., et al. (2008). Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 319, 1536-1539. (Pubitemid 351398184)
53. Geracioti, T.D., Jr., Carpenter, L.L., Owens, M.J., Baker, D.G., Ekhator, N.N., Horn, P.S., Strawn, J.R., Sanacora, G., Kinkead, B., Price, L.H., et al. (2006). Elevated cerebrospinal fluid substance P concentrations in posttraumatic stress disorder and major depression. Am. J. Psychiatry 163, 637-643. (Pubitemid 44464573)
54. Gerald, C., Adham, N., Kao, H.T., Olsen, M.A., Laz, T.M., Schechter, L.E., Bard, J.A., Vaysse, P.J., Hartig, P.R., Branchek, T.A., et al. (1995). The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J. 14, 2806-2815.
55. Gobbi, G., Murphy, D.L., Lesch, K.-P., and Blier, P. (2001). Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J. Pharmacol. Exp. Ther. 296, 987-995. (Pubitemid 32187374)
56. Gobbi, G., Bambico, F.R., Mangieri, R., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M.G., Debonnel, G., Duranti, A., et al. (2005). Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Nat. Acad. Sci. USA 102, 18620-18625. (Pubitemid 43011275)
57. Gobbi, G., Cassano, T., Radja, F., Morgese, M., Cuomo, V., Santarelli, L., Hen, R., and Blier, P. (2007). Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. Eur. Neuropsychopharmacol. 17, 328-338.
58. Greenberg, B.D., Tolliver, T.J., Huang, S.-J., Li, Q., Bengel, D., and Murphy, D.L. (1999). Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 88, 83-87. (Pubitemid 29075327)
59. Gross, C., Zhuang, X., Stark, K., Ramboz, S., Oosting, R., Kirby, L., Santarelli, L., Beck, S., and Hen, R. (2002). Serotonin-1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416, 396-400. (Pubitemid 34272867)
60. Guiard, B.P., Mansari, M.E., Murphy, D.L., and Blier, P. (2012). Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study. Int. J. Neuropsychopharmacol. 15, 349-361.
61. Guilloux, J., David, D., Guiard, B., Chenu, F., Reperant, C., Toth, M., Bourin, M., and Gardier, A. (2006). Blockade of 5-HT 1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT 1A receptor knockout mice. Neuropsychopharmacology 31, 2162-2172. (Pubitemid 44413193)
62. Gunther, L., Rothe, J., Rex, A., Voigt, J., Millan, M., Fink, H., and Bert, B. (2011). 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test. Neuropharmacology 61, 433-441.
63. Haddjeri, N. and Blier, P. (2001). Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission. Biol. Psychiatry 50, 191-199. (Pubitemid 32763097)
64. Haenisch, B. and Bönisch, H. (2011). Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol. Ther. 129, 352-368.
65. Hargreaves, R. (2002). Imaging substance P receptors (NK1) in the living human brain using positron emission tomography. J. Clin. Psychiatry 63, 18-24. (Pubitemid 35435004)
66. Haring, M., Marsicano, G., Lutz, B., and Monory, K. (2007). Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 146, 1212-1219. (Pubitemid 46694132)
67. Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., Bengel, D., and Lesch, K. (1996). Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66, 2621-2624. (Pubitemid 26159101)
68. Heisler, L.K., Chu, H.-M., Brennan, T.J., Danao, J.A., Bajwa, P., Parsons, L.H., and Tecott, L.H. (1998). Elevated anxiety and antidepressant-like responses in serotonin 5-HT 1A receptor mutant mice. Proc. Nat. Acad. Sci. USA 95, 15049-15054. (Pubitemid 29003754)
69. Hervieu, G.J., Cluderay, J.E., Gray, C.W., Green, P.J., Ranson, J.L., Randall, A.D., and Meadows, H.J. (2001). Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS. Neuroscience 103, 899-919. (Pubitemid 32289303)
70. Heurteaux, C., Guy, N., Laigle, C., Blondeau, N., Duprat, F., Mazzuca, M., Lang-Lazdunski, L., Widmann, C., Zanzouri, M., Romey, G., et al. (2004). TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J. 23, 2684-2695. (Pubitemid 38988239)
71. Heurteaux, C., Lucas, G., Guy, N., El Yacoubi, M., Thummler, S., Peng, X.D., Noble, F., Blondeau, N., Widmann, C., Borsotto, M., et al. (2006). Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat. Neurosci. 9, 1134-1141. (Pubitemid 44306306)
72. Hill, M.N., Miller, G.E., Ho, W.S., Gorzalka, B.B., and Hillard, C.J. (2008). Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry 41, 48-53. (Pubitemid 351427522)
73. Hill, M.N., Miller, G.E., Carrier, E.J., Gorzalka, B.B., and Hillard, C.J. (2009). Circulating endocannabinoids and n-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 34, 1257-1262.
74. Hillard, C.J., Edgemond, W.S., Jarrahian, A., and Campbell, W.B. (1997). Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem. 69, 631-638 (Pubitemid 27327964)
75. Holmes, A., Yang, R.J., Murphy, D.L., and Crawley, J.N. (2002). Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27, 914-923. (Pubitemid 35447628)
76. Janusonis, S., Anderson, G., Shifrovich, I., and Rakic, P. (2006). Ontogeny of brain and blood serotonin levels in 5-HT receptor knockout mice: potential relevance to the neurobiology of autism. J. Neurochem. 99, 1019-1031. (Pubitemid 44583458)
77. Jean, A., Conductier, G., Manrique, C., Bouras, C., Berta, P., Hen, R., Charnay, Y., Bockaert, J., and Compan, V. (2007). Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens. Proc. Nat. Acad. Sci. USA 104, 16335-16340. (Pubitemid 350099405)
78. Karg, K., Burmeister, M., Shedden, K., and Sen, S. (2011). The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch. Gen. Psychiatry 68, 444-454.
79. Kennett, G.A., Bright, F., Trail, B., Blackburn, T.P., and Sanger, G.J. (1997). Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats. Neuropharmacology 36, 707-712. (Pubitemid 27272117)
80. Kim, D.-K., Tolliver, T.J., Huang, S.-J., Martin, B.J., Andrews, A.M., Wichems, C., Holmes, A., Lesch, K.-P., and Murphy, D.L. (2005). Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49, 798-810. (Pubitemid 41483886)
81. Knobelman, D.A., Hen, R., and Lucki, I. (2001). Genetic regulation of extracellular serotonin by 5-hydroxytryptamine 1A and 5-hydroxytryptamine 1B autoreceptors in different brain regions of the mouse. J. Pharmacol. Exp. Ther. 298, 1083-1091. (Pubitemid 32761924)
82. Kobilka, B., Frielle, T., Collins, S., Yang-Feng, T., Kobilka, T., Francke, U., Lefkowitz, R., and Caron, M. (1987). An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329, 75-79. (Pubitemid 17125898)
83. Kramer, M.S., Cutler, N., Feighner, J., Shrivastava, R., Carman, J., Sramek, J.J., Reines, S.A., Liu, G., Snavely, D., Wyatt-Knowles, E., et al. (1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281, 1640-1645. (Pubitemid 28435572)
84. Lai, J.-P., Lai, S., Tuluc, F., Tansky, M.F., Kilpatrick, L.E., Leeman, S.E., and Douglas, S.D. (2008). Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor. Proc. Nat. Acad. Sci. USA 105, 12605-12610.
85. Lemonde, S., Turecki, G., Bakish, D., Du, L., Hrdina, P.D., Bown, C.D., Sequeira, A., Kushwaha, N., Morris, S.J., Basak, A., et al. (2003). Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 23, 8788-8799. (Pubitemid 37176660)
86. Lesch, K.-P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., Petri, S., Benjamin, J., Müller, C.R., Hamer, D.H., and Murphy, D.L. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531. (Pubitemid 26403928)
87. Lewis, G., Mulligan, J., Wiles, N., Cowen, P., Craddock, N., Ikeda, M., Grozeva, D., Mason, V., Nutt, D., Sharp, D., et al. (2011). Polymorphism of the 5-HT transporter and response to anti depressants: randomised controlled trial. Br. J. Psychiatry 198, 464-471.
88. Li, Q., Wichems, C.H., Ma, L., Van de Kar, L.D., Garcia, F., and Murphy, D.L. (2003). Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. J. Neurochem. 84, 1256-1265. (Pubitemid 36343592)
89. Liou, Y.-J., Chen, T.-J., Tsai, S.-J., Yu, Y.W.-Y., Cheng, C.-Y., and Hong, C.-J. (2009). Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. Pharmacogenet. Genomics 19, 735-741.
90. Lira, A., Zhou, M., Castanon, N., Ansorge, M.S., Gordon, J.A., Francis, J.H., Bradley-Moore, M., Lira, J., Underwood, M.D., Arango, V., et al. (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54, 960-971. (Pubitemid 37415032)
91. Lopez-Figueroa, A., Norton, C., Lopez-Figueroa, M., Armellini- Dodel, D., Burke, S., Akil, H., Lopez, J., and Watson, S. (2004). Serotonin 5-HT 1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol. Psychiatry 55, 225-233. (Pubitemid 38117158)
92. Lucas, G. (2009). Serotonin receptors, type 4: a new hope? Curr. Drug Targets 10, 1085-1095.
93. Lucas, G., Rymar, V.V., Du, J., Mnie-Filali, O., Bisgaard, C., Manta, S., Lambas-Senas, L., Wiborg, O., Haddjeri, N., Pineyro, G., et al. (2007). Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55, 712-725. (Pubitemid 47334877)
94. Mann, J.J., Huang, Y.-y., Underwood, M.D., Kassir, S.A., Oppenheim, S., Kelly, T.M., Dwork, A.J., and Arango, V. (2000). A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry 57, 729-738. (Pubitemid 30650106)
95. Mathews, T.A., Fedele, D.E., Coppelli, F.M., Avila, A.M., Murphy, D.L., and Andrews, A.M. (2004). Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J. Neurosci. Methods 140, 169-181. (Pubitemid 39625865)
96. Mayorga, A.J., Dalvi, A., Page, M.E., Zimov-Levinson, S., Hen, R., and Lucki, I. (2001). Antidepressant-like behavioral effects in 5-hydroxytryptamine 1A and 5-hydroxytryptamine 1B receptor mutant mice. J. Pharmacol. Exp. Ther. 298, 1101-1107. (Pubitemid 32761926)
97. Mazella, J., Petrault, O., Lucas, G., Deval, E., Beraud-Dufour, S., Gandin, C., El-Yacoubi, M., Widmann, C., Guyon, A., Chevet, E., et al. (2010). Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol. 8, e1000355.
98. Medhurst, A.D., Rennie, G., Chapman, C.G., Meadows, H., Duckworth, M.D., Kelsell, R.E., Gloger, I.I., and Pangalos, M.N. (2001). Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res. Mol. Brain Res. 86, 101-114. (Pubitemid 32124764)
99. Millstein, R. and Holmes, A. (2007). Effects of repeated maternal separation on anxiety- and depression-related phenotypes in different mouse strains. Neurosci. Biobehav. Rev. 31, 3-17. (Pubitemid 44880075)
100. Montañez, S., Owens, W.A., Gould, G.G., Murphy, D.L., and Daws, L.C. (2003). Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J. Neurochem. 86, 210-219. (Pubitemid 36753861)
101. Monteleone, P., Bifulco, M., Maina, G., Tortorella, A., Gazzerro, P., Proto, M.C., Di Filippo, C., Monteleone, F., Canestrelli, B., Buonerba, G., et al. (2010). Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression. Pharmacol. Res. 61, 400-404.
102. Murphy, D.L., Lerner, A., Rudnick, G., and Lesch, K.-P. (2004). Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol. Interv. 4, 109-123. (Pubitemid 38584973)
103. Murphy, D., Fox, M., Timpano, K., Moya, P., Ren-Patterson, R., Andrews, A., Holmes, A., Lesch, K., and Wendland, J. (2008). How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 55, 932-960.
104. Murphy, D.L. and Moya, P.R. (2011). Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease. Curr. Opin. Pharmacol. 11, 3-10.
105. Nichols, D.E. and Nichols, C.D. (2008). Serotonin receptors. Chem. Rev. 108, 1614-1641. (Pubitemid 351796401)
106. Ohtsuki, T., Ishiguro, H., Detera-Wadleigh, S.D., Toyota, T., Shimizu, H., Yamada, K., Yoshitsugu, K., Hattori, E., Yoshikawa, T., and Arinami, T. (2002). Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in japanese case-control samples and the NIMH genetics initiative bipolar pedigrees. Mol. Psychiatry 7, 954-961. (Pubitemid 35333050)
107. Olsson, C.A., Foley, D.L., Parkinson-Bates, M., Byrnes, G., McKenzie, M., Patton, G.C., Morley, R., Anney, R.J., Craig, J.M., and Saffery, R. (2010). Prospects for epigenetic research within cohort studies of psychological disorder: a pilot investigation of a peripheral cell marker of epigenetic risk for depression. Biol. Psychol. 83, 159-165.
108. Overstreet, D.H. (2012). Modeling depression in animal models. Methods Mol. Biol. 829, 125-144.
109. Parks, C.L., Robinson, P.S., Sibille, E., Shenk, T., and Toth, M. (1998). Increased anxiety of mice lacking the serotonin 1A receptor. Proc. Nat. Acad. Sci. USA 95, 10734-10739.
110. Parsey, R.V., Hastings, R.S., Oquendo, M.A., Huang, Y.-Y., Simpson, N., Arcement, J., Huang, Y., Ogden, R.T., Van Heertum, R.L., Arango, V., et al. (2006a). Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am. J. Psychiatry 163, 52-58. (Pubitemid 43050103)
111. Parsey, R.V., Olvet, D., Oquendo, M., Huang, Y., Ogden, R., and Mann, J. (2006b). Higher 5-HT 1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31, 1745-1749. (Pubitemid 44106705)
112. Parsey, R., Ogden, R., Miller, J., Tin, A., Hesselgrave, N., Goldstein, E., Mikhno, A., Milak, M., Zanderigo, F., Sullivan, G., et al. (2010). Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol. Psychiatry 68, 170-178.
113. Patel, A.J. and Honore, E. (2001). Properties and modulation of mammalian 2P domain K+ channels. Trends Neurosci. 24, 339-346. (Pubitemid 32455435)
114. Pazos, A. and Palacios, J.M. (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346, 205-230. (Pubitemid 16241111)
115. Perlis, R.H., Moorjani, P., Fagerness, J., Purcell, S., Trivedi, M.H., Fava, M., Rush, A.J., and Smoller, J.W. (2008). Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study. Neuropsychopharmacology 33, 2810-2819.
116. Pineyro, G. and Blier, P. (1999). Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 51, 533-591. (Pubitemid 29420214)
117. Popa, D., Léna, C., Alexandre, C., and Adrien, J. (2008). Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J. Neurosci. 28, 3546-3554.
118. Ramamoorthy, S., Bauman, A.L., Moore, K.R., Han, H., Yang-Feng, T., Chang, A.S., Ganapathy, V., and Blakely, R.D. (1993). Anti depressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Nat. Acad. Sci. USA 90, 2542-2546. (Pubitemid 23078664)
119. Ramboz, S., Oosting, R., Amara, D.A., Kung, H.F., Blier, P., Mendelsohn, M., Mann, J.J., Brunner, D., and Hen, R. (1998). Serotonin receptor 1A knockout: an animal model of anxietyrelated disorder. Proc. Nat. Acad. Sci. USA 95, 14476-14481. (Pubitemid 28549392)
120. Reynolds, G.P., Mason, S.L., Meldrum, A., De Keczer, S., Parnes, H., Eglen, R.M., and Wong, E.H. (1995). 5-hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br. J. Pharmacol. 114, 993-998.
121. Richardson-Jones, J., Craige, C., Guiard, B., Stephen, A., Metzger, K., Kung, H., Gardier, A., Dranovsky, A., David, D., Beck, S., et al. (2010). 5-HT 1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65, 40-52.
122. Richardson-Jones, J.W., Craige, C.P., Nguyen, T.H., Kung, H.F., Gardier, A.M., Dranovsky, A., David, D.J., Guiard, B.P., Beck, S.G., Hen, R., et al. (2011). Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J. Neurosci. 31, 6008-6018.
123. Richer, M., Hen, R., and Blier, P. (2002). Modification of serotonin neuron properties in mice lacking 5-HT 1A receptors. Eur. J. Pharmacol. 435, 195-203. (Pubitemid 34131700)
124. Rimon, R., Le Greves, P., Nyberg, F., Heikkila, L., Salmela, L., and
125. Rioux, A., Fabre, V., Peter Lesch, K., Moessner, R., Murphy, D.L., Lanfumey, L., Hamon, M., and Martres, M.-P. (1999). Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter. Neurosci. Lett. 262, 113-116. (Pubitemid 29130301)
126. Rogawaski, M. and Aghajanian, G. (1981). Serotonin autoreceptors on dorsal raphe neurons: structure-activity relationships of tryptamine analogs. J. Neurosci. 1, 1148-1154. (Pubitemid 12218107)
127. Rosel, P., Arranz, B., Urretavizcaya, M., Oros, M., San, L., and Navarro, M.A. (2004). Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims. Neuropsychobiology 49, 189-195. (Pubitemid 38594570)
128. Rudnick, G. and Clark, J. (1993). From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim. Biophys. Acta 1144, 249-263. (Pubitemid 23290252)
129. Rupniak, N., Carlson, E., Webb, J., Harrison, T., Porsolt, R., Roux, S., de Felipe, C., Hunt, S., Oates, B., and Wheeldon, A. (2001). Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs. Behav. Pharmacol. 12, 497-508. (Pubitemid 33152274)
130. Santarelli, L., Gobbi, G., Debs, P.C., Sibille, E.L., Blier, P., Hen, R., and Heath, M.J.S. (2001). Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxietyrelated behaviors and increases serotonergic function. Proc. Nat. Acad. Sci. USA 98, 1912-1917. (Pubitemid 32165597)
131. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809. (Pubitemid 36962615)
132. Saveanu, R.V. and Nemeroff, C.B. (2012). Etiology of depression: genetic and enviromental factors. Psychiatr. Clin. North Am. 35, 51-71.
133. Sharp, T. and Hjorth, S. (1990). Application of brain microdialysis to study the pharmacology of the 5-HT 1A autoreceptor. J. Neurosci. Methods 34, 83-90. (Pubitemid 20301325)
134. Shirayama, Y., Mitsushio, H., Takashima, M., Ichikawa, H., and Takahashi, K. (1996). Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat. Brain Res. 739, 70-78. (Pubitemid 26387364)
135. Slattery, D.A., Markou, A., and Cryan, J.F. (2007). Evaluation of reward processes in an animal model of depression. Psychopharmacol. (Berl.) 190, 555-568. (Pubitemid 46204472)
136. Sotelo, C., Cholley, B., El Mestikawy, S., Gozlan, H., and Hamon, M. (1990). Direct immuno-histochemical evidence of the existence of 5-HT 1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur. J. Neurosci. 2, 1144-1154.
137. Stockmeier, C., Dilley, G., Shapiro, L., Overholser, J., Thompson, P., and Meltzer, H. (1997). Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 16, 162-173. (Pubitemid 27086431)
138. Stockmeier, C., Shi, X., Konick, L., Overholser, J., Jurjus, G., Meltzer, H., Friedman, L., Blier, P., and Rajkowska, G. (2002). Neurokinin-1 receptors are decreased in major depressive disorder. Neuroreport 13, 1223-1227. (Pubitemid 34722058)
139. Stockmeier, C., Howley, E., Shi, X., Sobanska, A., Clarke, G., Friedman, L., and Rajkowska, G. (2009). Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder. J. Psychiatr. Res. 43, 887-894.
140. Talley, E.M., Solorzano, G., Lei, Q., Kim, D., and Bayliss, D.A. (2001). CNS distribution of members of the two-pore-domain (KCNK) potassium channel family. J. Neurosci. 21, 7491-7505. (Pubitemid 32904948)
141. Tecott, L.H. and Wehner, J.M. (2001). Mouse molecular genetic technologies: promise for psychiatric research. Arch. Gen. Psychiatry 58, 995-1004. (Pubitemid 33051825)
142. Tyndale, R., Payne, J., Gerber, A., and Sipe, J. (2007). The fatty acid amide hydrolase c385a (P129T) missense variant in cannabis users: studies of drug use and dependence in caucasians. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B, 660-666. (Pubitemid 47077151)
143. Uher, R. (2011). Genes, environment, and individual differences in responding to treatment for depression. Harv. Rev. Psychiatry 19, 109-124.
144. Valentino, R.J., Bey, V., Pernar, L., and Commons, K.G. (2003). Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity. J. Neurosci. 23, 7155-7159. (Pubitemid 36975879)
145. Van den Wyngaert, I., Gommeren, W., Verhasselt, P., Jurzak, M., Leysen, J., Luyten, W., and Bender, E. (1997). Cloning and expression of a human serotonin 5-HT4 receptor cDNA. J. Neurochem. 69, 1810-1819. (Pubitemid 27452725)
146. Wellman, C.L., Izquierdo, A., Garrett, J.E., Martin, K.P., Carroll, J., Millstein, R., Lesch, K.-P., Murphy, D.L., and Holmes, A. (2007). Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J. Neurosci. 27, 684-691. (Pubitemid 46143772)
147. Willner, P. (1984). The validity of animal models of depression. Psychopharmacol. (Berl.) 83, 1-16. (Pubitemid 14141479)
148. Willner, P. (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90-110. (Pubitemid 41160326)
149. Willner, P., Towell, A., Sampson, D., Sophokleous, S., and Muscat, R. (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacol. (Berl.) 93, 358-364. (Pubitemid 17160661)
150. Zhang, H., Smith, G.N., Liu, X., and Holden, J.J.A. (2010). Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas. Physiol. Genomics 42, 85-92.
151. Zhao, S., Edwards, J., Carroll, J., Wiedholz, L., Millstein, R.A., Jaing, C., Murphy, D.L., Lanthorn, T.H., and Holmes, A. (2006). Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience 140, 321-334. (Pubitemid 43668455)